Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.
Mohan M, Becnel MR, Shah UA, Dong H, Gundarlapalli S, Peterson T, Orozco JS, Horowitz S, Chhabra S, Dhakal B, Thanendrarajan S, Radhakrishnan SV, Al Hadidi S, Tan C, Mailankody S, Hultcrantz M, Korde N, Hassoun H, Lesokhin AM, Thomas SK, Patel KK, Manasanch EE, Weber DM, Szabo A, Kaufman GP, Lee HC, Zangari M, van Rhee F, Usmani SZ, D'Souza A, Orlowski RZ, Schinke C. Mohan M, et al. Among authors: mailankody s. Am J Hematol. 2022 Jul;97(7):E276-E280. doi: 10.1002/ajh.26580. Epub 2022 May 2. Am J Hematol. 2022. PMID: 35472167 Free PMC article. No abstract available.
Second malignancies after multiple myeloma: from 1960s to 2010s.
Thomas A, Mailankody S, Korde N, Kristinsson SY, Turesson I, Landgren O. Thomas A, et al. Among authors: mailankody s. Blood. 2012 Mar 22;119(12):2731-7. doi: 10.1182/blood-2011-12-381426. Epub 2012 Feb 6. Blood. 2012. PMID: 22310913 Free PMC article. Review.
Smoldering multiple myeloma: present position and potential promises.
Tageja N, Manasanch EE, Korde N, Kwok M, Mailankody S, Bhutani M, Roschewski M, Landgren O. Tageja N, et al. Among authors: mailankody s. Eur J Haematol. 2014 Jan;92(1):1-12. doi: 10.1111/ejh.12205. Epub 2013 Nov 26. Eur J Haematol. 2014. PMID: 24112232 Review.
Minimal residual disease: what are the minimum requirements?
Roschewski M, Stetler-Stevenson M, Yuan C, Mailankody S, Korde N, Landgren O. Roschewski M, et al. Among authors: mailankody s. J Clin Oncol. 2014 Feb 10;32(5):475-6. doi: 10.1200/JCO.2013.52.1955. Epub 2014 Jan 13. J Clin Oncol. 2014. PMID: 24419126 No abstract available.
Dilemmas in treating smoldering multiple myeloma.
Ahn IE, Mailankody S, Korde N, Landgren O. Ahn IE, et al. Among authors: mailankody s. J Clin Oncol. 2015 Jan 1;33(1):115-23. doi: 10.1200/JCO.2014.56.4351. Epub 2014 Nov 24. J Clin Oncol. 2015. PMID: 25422486 Free PMC article. Review.
The road to treating smoldering multiple myeloma.
Korde N, Mailankody S, Landgren O. Korde N, et al. Among authors: mailankody s. Clin Lymphoma Myeloma Leuk. 2014 Sep;14 Suppl:S59-64. doi: 10.1016/j.clml.2014.04.012. Clin Lymphoma Myeloma Leuk. 2014. PMID: 25486957 Review.
165 results